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Summary
CD21int CD23+ IgM+ mouse follicular B cells comprise the bulk of the
mature B-cell compartment, but it is not known whether these cells con-
tribute to the humoral antibody response. We show using a direct RT-
PCR method for antigen-specific VH, that FACS-sorted mouse
CD21int CD23+ B cells express specific secretory IgM VH transcripts in
response to immunization and also exhibit a memory response. The secre-
tory IgM expressed is distinct from the IgG expressed by cells of this phe-
notype, which we also analyse here, having a distinct broader distribution
of CDR-H3 sequences and zero or low levels of somatic mutation in the
region analysed. These results imply that cells of the CD21int CD23+ phe-
notype have distinct IgM+ and IgG+ populations that contribute directly
to the humoral antibody and memory responses by expressing antigen-
specific secretory immunoglobulin. We also argue that the more diverse
CDR-H3 sequences expressed by antigen-experienced IgM+ CD21int
CD23+ follicular B cells would place them at the bottom of a recently
hypothesized memory B-cell hierarchy.
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Introduction
Recent studies on antibody responses suggest that the
memory B-cell compartment is diverse and may contain
cells not previously considered to be memory B cells, as
they have some characteristics of naive cells.1
The bulk of the mouse mature ‘naive’ B-cell compart-
ment is comprised of CD21int CD23+ follicular B cells
that express IgM and IgD. These cells are able to re-circu-
late and home to B-cell follicles in secondary lymphoid
tissue where they are well placed to initiate antibody
responses.2–4 Follicular B cells show functional plasticity;
as well as their role in initiating T-cell-dependent
responses and affinity maturation in germinal centres,
they also participate in T-cell-independent responses in
the bone marrow,5 and may act as marginal zone B-cell
precursors.6
B-cell receptor signalling is important in the develop-
ment and survival of mature B cells,7–11 and the strength
of signalling is proposed as a factor during follicular B-
cell development.4 Self antigens,12 and perhaps gut
flora,12,13 have been proposed as drivers of marginal zone
B-cell development, and it has recently been shown that
foreign antigen can select certain VH into the marginal
zone antibody repertoire,14 but the situation with follicu-
lar B-cell selection is less clear.
The CD21int CD23+ IgM+ population has long been
assumed to be naive. Although follicular cells usually have
a lifespan of several weeks this is probably extendable
depending on homeostatic forces and quality of B-cell
receptor stimulation.3,15–17 It is not clear, therefore, how
smoothly distributed the clonality is in the follicular pop-
ulation; whether there are as many different clones as
cells – perfectly smooth – or whether some clones are
larger or have longer lifespans, perhaps due to foreign
antigen stimulation.
Recent studies on memory B cells have shown that they
can be of either IgM or IgG isotype. Memory cells may
also reside in the follicular areas as well as the marginal
zone of the spleen18 and may not have gone through ger-
minal centres.19,21 Because of this diversity in the B-cell
memory compartment,18–21 and the likelihood that this
Abbreviations: C6, the 6 amino-acid CDR-H3 of particular VHOx-1 transcripts; CSA, chicken serum albumin; phOx, phenyl-
oxazolone
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compartment is organized as a hierarchy to maximize
adaptability,19,21–23 and includes IgM+ IgD+ cells with few
or no VH mutations,19 a question has to be asked about
what relationship CD21int CD23+ IgM+ follicular B cells
have to the memory compartment, and whether perhaps
some of them represent the bottom, most ‘naive-like’22
part of the memory hierarchy. A current definition of a
memory cell involves it having experienced antigen and
subsequently being in a resting state, and then being cap-
able of secondary activation.18,20 Follicular B cells could
fulfil these criteria if foreign antigens stimulated increased
recruitment, division or survival without a subsequent
differentiation further into the memory/effector response.
This would form a memory pool of the sort described for
T-independent antigens, that is not necessarily long lived
and is caused by an increase in precursor frequency rather
than affinity.20
Antigen-specific follicular B cells are rare, being present
at a frequency in the order of 104 in naive mice.19 For
certain antigens it is possible to use RT-PCR to analyse
antibody expression, and this represents an ideal
approach to directly assess specific antibody expression by
rare cells in a large population. We have previously
reported the use of immunoglobulin RT-PCR to detect
expression of phenyl-oxazolone (phOx) -specific VH.14,24
This method is an adaptation of the method of ‘spec-
tratyping’.25 A further feature of the phOx response is
that all reported hybridomas and all secretory IgG we
detect by RT-PCR, with the VHOx-1 heavy chain, contain
a particular CDR-H3 motif containing a DXG sequence,
the basis of the Ox idiotype.24,26,27 This DXG motif is,
therefore, a useful marker for the presence of presumptive
higher affinity VH. The phOx-specific DXG-motif-con-
taining CDR-H3 is always six amino acids long. In the
RT-PCR analysis reported in this study we refer to
VHOx-1 transcripts encoding CDR-H3s of this length as
C6 transcripts. As the modal VHOx-1 CDR-H3 length is
ten, C6 transcripts appear four codon units down from
these on gels. The phOx/RT-PCR method is highly repro-
ducible, detecting up-regulated IgM and/or IgG tran-
scripts in every immunized mouse of the appropriate IgH
haplotype.14,24,28 Further, for reasons dealt with in depth
elsewhere,14 the RT-PCR method used is independent of
known mechanisms of PCR bias.
To address the question of whether the CD21int
CD23+ IgM+ splenic B-cell population shows any mem-
ory capacity, we have conducted an analysis of secretory
VHOx-1 IgM expression on FACS-sorted cells at various
times after phOx immunization/re-challenge. We show
that CD21int CD23+ B cells express a diverse repertoire of
secretory IgM mRNA in unimmunized mice, that antigen
priming induces a significant up-regulation of specific
secretory IgM expression by these cells, and that they also
show a memory/recall response. By analysing IgG expres-
sion in the same population we also show that this IgM
memory response is distinct from that expressed by
CD21int CD23+ IgG+ cells.
Materials and methods
Mice
All mice were female BALB/c (Harlan, Bicester, UK), 6–
8 weeks old at day 0. Age-matched controls were 14
weeks old. Mice were maintained in the Institute of Child
Health Biological Services Unit in compliance with UK
Home Office Animals (Scientific Procedures) Act 1986
Guidelines and experiments were performed under the
protocols of a UK Home Office Animal Project license #
70/05954, approved by the animal experimentation ethics
committee of the UCL/Institute of Child Health.
Immunization
The hapten-carrier phOx-CSA was made as described
previously.28,29 For primary immunizations (day 0)
100 lg of alum-precipitated phOx-CSA with 109 heat-
killed pertussis was injected intraperitoneally. For boost-
ing (day 50) 100 lg soluble phOx-CSA in PBS was
injected iintraperitoneally.
FACS sorting
Eighty-six per cent of a whole sieved spleen cell suspen-
sion was incubated in 1 ml medium with 10% fetal calf
serum and 1/50 Fc Block (BD Pharmingen, Oxford, UK)
for 15 min on ice, before incubation with 1/50 dilutions
of appropriate antibodies for 30 min on ice. Most anti-
bodies were obtained from BD Pharmingen including
FITC-conjugated anti-CD21 (clone 7G6) and phycoery-
thrin-conjugated anti-CD23 (clone B3B4). Cy-chrome
(phycoerythrin-Cy5) -conjugated anti-CD19 (clone 6D5)
was obtained from AbD Serotec/BioRad (Kidlington,
Oxford, UK). Cells were washed and sorted on a Beck-
man-Coulter Altra. Between 1 9 106 and 3 9 106 follicu-
lar B cells were recovered from each sample.
RNA extraction/RT-PCR
This method has been described elsewhere.24 Briefly, total
RNA extraction was performed using the RNA Bee
reagent (Amsbio, Abingdon, UK) according to the manu-
facturer’s instructions. Twenty per cent of the RNA
obtained from a whole cell-sort sample was denatured at
96° for 3 min with 05 lg oligo-dT and placed on ice
before reverse transcription in a 50-ll reaction for 1 hr at
42° with 19 RT buffer, 02 mM dNTPs, 1 mM dithiothre-
itol, 800 Uml-1 RNAsin (Promega, Southampton, UK)
and 200 U Superscript II reverse transcriptase. After heat
inactivation, reactions were digested for 20 min with 2 U
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RNase H (all Thermo Fisher, Paisley, UK except where
indicated).
First-round PCR was done with 2 ll of cDNA reaction
with standard reaction conditions using the manufac-
turer-supplied buffer with Hotstart Pfu turbo polymerase
(Agilent Stratagene, Stockport, UK) and 25 pmol of the
appropriate primer in a 50-ll reaction for 34 cycles with
the following cycling: 96°, 30 seconds; 59°, 30 seconds;
72°, 2 min; preceded by an incubation at 96° for 3 min.
All primers used are described elsewhere.24
Run-offs
For each single run-off reaction equivalent 2 pmol nested
isotype-specific primer was end-labelled with 1 lCi c33P
dATP (2500 Ci/mmol, GE Healthcare, Chalfont St Giles,
UK) using the T4 polynucleotide kinase labelling system
(GE Healthcare). The reaction was sodium acetate/ethanol
precipitated and washed with 75% ethanol before use.
Run-off reactions were performed for 12 cycles in a 20-ll
volume with Hotstart Pfu-turbo polymerase and buffer as
before using 2 ll of the first-round PCR product with the
following cycling: 96°, 30 seconds; 60°, 30 seconds; 72°,
1 min. After cycling reactions, samples were treated as for
standard sequencing gel electrophoresis and run on 5%
acrylamide/urea gels, dried and exposed to X-ray film
(Kodak XAR).
Run-offs for quantification on the capillary DNA anal-
yser were prepared as follows: 2 ll of first-round PCR
was put into a total run-off reaction volume of 10 ll,
using buffers as above, with 1 pmol of FAM-labelled
nested run-off primer (Eurofins/MWG, Germany) and
cycled 10 times with the parameters as above. One
microlitre of run-off was diluted into 12 ll H2O and
035 ll of ROX size standards (GE Healthcare) were
added. Samples were analysed on an GE Megabace 500
using GENETIC PROFILER software (GE Healthcare). All pri-
mers used are described elsewhere.24
CDR-H3 sequence determination
For PAGE purification of ‘C6’ transcripts quadruple-sized
run-off samples were loaded on triple-width wells, elec-
trophoresed and located by autoradiography. Bands were
cut out from the dried gel with fine scissors, soaked for
10 min in 100 ll of water, heated to 100° for 15 min and
centrifuged at 21,000 g for 2 min. DNA was recovered
from the supernatant by addition of 10 lg of linear poly-
acrylamide and sodium acetate/ethanol precipitation on
dry ice. After centrifugation, the pellet was washed with
75% ethanol, air-dried and re-dissolved in 10 ll of water.
Six microlitres of this was used in a 50-ll, 15-cycle PCR
with Hot-start Pfu turbo polymerase and the manufac-
turer-supplied buffer with conditions as above and the
OXC2 and appropriate nested isotype-specific primer that
was also used in the run-off, with the following cycling:
94°, 30 seconds; 59°, 30 seconds; 72°, 1 min. Two micro-
litres of this product was Zero-Blunt TOPO-TA cloned,
transformed into Escherichia coli TOP-10 and plated out
on selective media according to the manufacturer’s
instructions (Thermo Fisher, Paisley, UK). Individual
colonies were picked and directly amplified for 25 cycles
with Hot-start Pfu-turbo (Agilent Stratagene, UK) condi-
tions as above, using the OXC2 and appropriate nested
isotype-specific primer. One microlitre of this product
was sequenced directly using the ABI Big-Dye kit (Life
Technologies) and sequenced on a GE Megabace 500
DNA analyser. Twenty-four colonies were picked and
sequenced for each sample. Only sequences with clean
reads and six-amino-acid CDR-H3s, that translated cor-
rectly from the beginning of VHOx-1 FR3 to GQG in JH
were used. For VHOx-1 IgG CDR-H3 sequence determi-
nation we adopted a direct approach. As VHOx-1 IgG is
not detected by RT-PCR in unimmunized mice, and as
the bulk of it in immunized mice is C6 transcripts, gel
purification after first-round PCR is not necessary. The
cDNA samples were amplified as in ‘RT-PCR’ above
using the VHOx-1primer and the common IgG secretory
form redundant primers G13sec: tcatttaccaggrgagygrga/
G2Absec: tcatttacccggagwccggga which were used at
equimolar concentrations, and common IgG membrane
form primer GMEM: caggaagaggctgatgaagatgg. These
samples were then subject to a nested amplification, as in
this section above, with a primer common for the CH1
of all IgG subclasses acacyrctggacagggmtcca, then TOPO
cloned and sequenced as above.
Results
Figure 1 shows the FACs gating and work flow to analyse
levels of antigen-specific transcripts in follicular B cells or
whole spleen cells. This method is dealt with in more
detail elsewhere.14 Whole spleen cells or FACS-sorted cells
were subject to secretory or membrane form-specific, iso-
type-specific, VH-specific RT-PCR. Amplified transcripts
were then subject to a nested isotype-specific FAM- or
33P-labelled run-off, to label the shorter FR3-CDR-H3-
JH-CH1 fragment for quantification on a DNA analyser
or visualization and DNA cloning.
The splenic secretory IgM response to phox
Groups of three mice were immunized with phOx-CSA
in an alum/pertussis adjuvant and analysed 4, 11 and
50 days later. A further group was re-immunized with
soluble phox-CSA at day 50 and analysed 4 days later.
Three unimmunized age-matched controls and three
memory controls primed with CSA/alum/pertussis and
re-immunized with soluble phOx-CSA were also included.
The upper panel of Fig. 2 shows the transcript profiles,
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the values for C6 transcript levels in each sample and the
frequency of the DXG motif within each C6 transcript
‘band’.
Expressing C6 transcript levels as the percentage of
transcript levels in all ‘bands’ in the VHOx-1 repertoire,
C6/(totalVHOx1-C6), provides a measure independent of
known mechanisms of PCR bias and allows a direct
quantification of C6 transcript levels. When the C6 gel
band is cloned from 33P-labelled gels and the CDR-H3
sequences in it determined, a measure is also possible of
the separate levels of phOx-induced C6 transcript with
and without the DXG CDR-H3 sequence motif.
Antigen priming induced a change in C6 transcript
levels, increasing from 112% to 262% by day 11.
Sequence analysis of the transcripts showed that about
three-quarters of this response was comprised of tran-
scripts without the DXG motif, compared with secretory
IgG transcripts from the spleen at this time-point, which
all contain the motif.24 By day 50, C6 secretory IgM tran-
scripts had returned to pre-immune levels. Re-challenge
with phOx induced a strong secondary, memory-type
response compared with the C6 levels seen in the carrier-
primed/phOx boosted group. This effect formed the basis
of our previous report of IgM memory.24 Here, we also
observed that C6 transcripts in the secondary response
contained an increase in the frequency of DXG motifs
compared with the antigen-primed samples (Fig. 2 and
Table 1). Also, comparing the levels of non-DXG and
DXG in C6 transcripts between boost and pre-immune
groups showed that the uplift in expression after boosting
can be mostly accounted for by DXG motif transcripts.
In summary, when analysed at the whole spleen level,
the primary secretory IgM response to phOx involved
expression of C6 transcripts mostly lacking the DXG
motif, whereas in the secondary response DXG-containing
transcripts largely accounted for the up-regulated C6
levels. Although, as detected here, there was not a differ-
ence between overall C6 transcript levels at day 11 after
priming and after boosting, 262% versus 297%, the sec-
ondary response was qualitatively different in containing
higher levels of the presumptive higher-affinity DXG
motif, and levels of C6 were much higher after boosting
than observed in the carrier-primed/phOx boosted mem-
ory control.
Cells with the CD21int CD23+ phenotype express
secretory IgM mRNA
FAC-sorted CD21int CD23+ cells were obtained from the
same spleen samples analysed above and subject to
VHOx-1 secretory IgM RT-PCR. The results and analysis
are shown in Fig. 3. The CD21int CD23+ population
expressed a diverse repertoire of secretory IgM transcripts
in unimmunized mice. Considering the abundance of this
population, comprising about 80% of splenic CD19+ B
cells, and the diversity of the repertoire, this observation
suggested that many CD21int CD23+ B cells contribute to
the plasma IgM pool.
CD21int CD23+ B cells express particular secretory
IgM transcripts in response to immunization
Figure 3 shows that phOx stimulated a significant increase
in C6 secretory IgM transcript expression in the
CD21int CD23+ population after 11 days (P = 00004,
Students t-test, see Fig. 3 legend). The increase in C6 tran-
scripts is accounted for by expression of C6 without the
DXG motif. Table 1 shows a summary of DXG frequency
in IgM and IgG C6 transcripts, up-regulated in response
to phOx immunization, in CD21int CD23+ cells. Although
few (42%) antigen-priming-induced secretory IgM tran-
scripts contained the motif, all tested secretory IgG tran-
scripts from the same sorted population were DXG+. We
have also included membrane IgG CDR-H3 data for this
population, which confirmed that memory-type mem-
brane IgG+, DXG-expressing cells were within the
CD21int CD23+ phenotype 11 days after phOx priming.
Hence, at 11 days after antigen priming, not all anti-
gen-responding CD21int CD23+ IgM+ cells had differenti-
ated and/or lost this phenotype. Those cells that retained
the phenotype expressed secretory IgM with the same VH
but distinct CDR-H3s to those seen in the IgG response,
which was also running at this time-point.
It is clear comparing the data and profiles from Figs 2
and 3, that the bulk of the VHOx-1/C6 secretory IgM
response to phOx detected by this method was produced
by CD21int CD23+ cells. This population comprises
around 80% of CD19+ splenic B cells, FACs sorting them
did not obviously change the profiles compared with

























VHOx-1 RT-PCR with 33P or FAM-
labelled nested run-off from FO spleen cells
PAGE and analysis to quantify levels of
PhOx-specific transcripts (see Ref. 14)
Figure 1. FACS gating and workflow for RT-PCR analysis of specific
antibody expression. Cell suspensions were sorted for CD19+
CD21int CD23+ cells when appropriate. Upper left hand panel shows
a typical sort and the follicular cell gate used. Upper right hand
panel shows a re-sort of CD21int CD23+ cells after sample sort was
completed.
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Figure 3 also shows that by 50 days after phOx priming,
levels of C6 secretory IgM transcripts had fallen to pre-
immune levels in these cells.
The CD21int CD23+ IgM+ B-cell population expresses
secretory IgM transcripts as a memory response
Figure 3 shows that rechallenge with phOx stimulated a
large increase in VHOx-1/C6 secretory IgM, 4 days after
re-challenge. Further, this response was significantly larger
(based on 95% confidence intervals) than that seen in the
carrier-primed/phOx boosted samples, 336% compared
with 72%.
Analysis of the transcripts in the boosted samples from
CD21int CD23+ cells showed that there was a mixture of
DXG and non-DXG. Table 1 shows that up-regulated
transcripts were approximately two-thirds DXG and
one-third non-DXG. Table 1 also shows that as with
phOx-primed cells, all the secretory IgG transcripts from
phOx-boosted CD21int CD23+ cells had DXG motif
CDR-H3s, showing again that the secretory IgM response
by this cell population involved a different subset of
VHOx-1 sequences. This observation was further sup-
ported by comparing the levels of somatic mutation in
the framework-3 region (FR3) from DXG+ C6 transcripts
between secretory IgM and secretory IgG in boosted mice,
see Table 1. After boosting, CD21int CD23+ B cells
expressed secretory IgG with a four-fold higher level of
somatic mutation in FR3 compared with that seen in
secretory IgM expressed by this population, 125% versus
028%. This distribution of somatic mutation, higher in
IgG-expressing cells, confirms that the CD21int CD23+
cells expressing IgM and IgG were distinct populations, at
the level of VH sequences.
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Figure 2. The VHOx-1 secretory IgM response to phenyl-oxazolone (phOx) at the whole spleen level. VHOx-1 secretory IgM RT-PCR of whole
spleen cell suspension cDNA. Cells from single mouse spleen per sample track. Three samples per group from one representative experiment.
Control, unimmunized; day 4: Four days after immunization with phOx-CSA/adjuvant; day 11: 11 days after immunization with phOx-CSA/ad-
juvant; day 50: 50 days after immunization with phOx-CSA/adjuvant; ox prime/ox boost: re-immunized with soluble phOx-CSA 50 days after
priming with phOx-CSA/adjuvant, samples collected 4 days later; carrier-prime/ox boost: re-immunized with soluble phOx-CSA 50 days after
priming with CSA/adjuvant, samples collected 4 days later. The C6 band, containing phOx-specific transcripts with six amino-acid CDR-H3s, is
indicated with an arrow. Numerical data derived as described ref. 14 C6 level %, the level of C6 transcripts in that sample as a percentage of the
levels of all other VHOx-1 transcript lengths. DXG/seq, the number of sequences in that C6 band containing the DXG motif out of all sequences
from that band. Mean C6 level, the mean level of C6 transcripts in that group. DXG, the mean level of DXG motif containing C6 transcripts in
that group as a percentage of all other VHOx-1. To calculate this mean value, the individual sample DXG values were calculated first, using indi-
vidual C6% 9 DXG/Seq values, and then averaged; Non DXG, the mean level of C6 transcripts without the DXG motif expressed as a percentage
of all other VHOx-1. Lower panel shows individual C6 levels plotted (dots) and the mean for each group (solid bar), and panels correspond to
those above.
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These observations also showed that not all primed, anti-
gen-responsive CD21int CD23+ IgG+ cells lose this pheno-
type after antigen re-challenge. We have also included
membrane IgG CDR-H3 data for this population, which
showed that memory-type, membrane IgG-expressing,
DXG-expressing cells remain within the CD21int CD23+
phenotype 4 days after boosting (Table 1).
Discussion
Using a simple immunization strategy and direct RT-PCR
for antigen-specific VH, we have shown that
CD21int CD23+ B cells express antigen-specific secretory
IgM mRNA and exhibit a memory response. The IgM
expressed in these circumstances is distinct from the IgG
expressed by cells of the same phenotype both by compo-
sition of the CDR-H3 and by level of somatic mutation
in the FR3 region, indicating the presence of two different
antigen-experienced sub-populations within the larger
CD21int CD23+ phenotype. Further, the secretory IgM
memory response of these cells is qualitatively different
from the primary response by this population, containing
a higher frequency of the presumptive high-affinity DXG
motifs and is also expressed at higher level compared
with the carrier-primed memory control group. We note
that the secretory IgM VHOx-1/C6 primary response
reported here is higher than in one of our previous stud-
ies,24 and conclude that this is due to the higher antigen
dose of 100 lg used in the current study compared with
30 lg previously. We used this higher dose of antigen as
we theorized that it was more likely to stimulate
responses in the follicular cell population, perhaps by cells
with lower affinity VH.
For particular cells in the follicular cell pool to be stimu-
lated by foreign antigen and express specific secretory IgM,
but not undergo a net decrease in cell numbers, we suggest
that they are probably expressing B-cell receptor that gives
an appropriate level of stimulation but does not bind anti-
gen strongly enough to drive them into a T-dependent
response, but does stimulate the B-cell receptor enough to
increase recruitment into the follicular pool or increase cell
division or survival. In the diverse repertoire of
CD21int CD23+ IgM one would expect some VH with these
characteristics of intermediate affinity to a challenging anti-
gen, and the prediction would be that these would be dis-
tinct sequences from those found in IgG. This is what we
have observed in this study, as the frequency of the DXG
motif differs between the IgM+ and IgG+ populations.
As well as the difference in the presence of the DXG
motif between IgM and IgG transcripts, the differing
levels of somatic mutation that we have observed in the
FR3 region of VHOx-1 after boosting, 028% in secretory
IgM and 125% in secretory IgG expressing cells, confirms
that the CD21int CD23+ cells responding to re-challenge
by expressing IgM and IgG are distinct populations. It is
not possible to know, however, whether this class switch-
ing happened before or after boosting, as antigen re-chal-
lenge could have stimulated rapid class switching from
Table 1. Frequency of, and mutation in, the DXG motif transcripts up-regulated in response to phenyl-oxazolone







Secretory IgM 253 00 (0/7) 941 035 (15/37)
CD21int CD23+ cells
Secretory IgM 42 00 (0/2) 636 028 (7/21)
Membrane IgM 642 032 (11/29) 593 039 (6/13)
Secretory IgG 1000 (34/34) 02 (9/34) 1000 (30/30) 125 (44/30)
Membrane IgG 952 (20/21) 047 (11/20) 1000 (40/40) 138 (65/40)
Estimated frequency in % of the DXG motif in transcripts expressed above pre-immune levels; and level of somatic mutation in the FR3 region
of the VHOx-1/DXG sequences. Day 11: 11 days after immunization with phOx-CSA/adjuvant, boost: re-immunized with soluble phOx-CSA 50
days after priming with CSA/adjuvant, samples collected 4 days later. % DXG: Proportion of phenyl-oxazolone (phOx) -induced transcripts that
contain DXG motif. For estimating % DXG in phOx-induced transcripts, IgM values were calculated from data in Figs 2 and 3, except mem-
brane IgM data which is derived from ref. 13 by subtracting the mean pre-immune values of DXG and non-DXG transcript levels from the
respective mean values for each experimental group and then calculating what percentage were DXG/non-DXG. For each experimental group,
between 42 and 57 DNA sequences were analysed in total for DXG from the three independent samples shown in these figures. VHOx-1/C6 IgG
is not readily detectable in pre-immune samples so all is assumed phOx-induced. Figures in brackets by IgG values show DXG/number of total
sequences analysed, a pool from the three independent samples in each group.
% mutation in DXG: Figures show % somatic mutation in the FR3 region of VHOx-1/C6 for all transcripts in group with DXG motif. Figures
in brackets show number of mutations/number of sequenced 117 bp FR3 regions.
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IgM by cells expressing the higher affinity and/or most
mutated VH.
By 11 days after priming the T-independent IgM
response has peaked and is fading.30,31 We suggest, both
because of the use of the VHOx-1/C6 VH and the
dynamics of the response, that the effects we are observ-
ing are the T-independent beginnings of the T-dependent
response to phOx. Current models of the memory com-
partment suggest a structured hierarchy with longer-lived
less-mutated IgM memory cells at the root.19,21,22 This
architecture allows maximum adaptability, whereby in
response to pathogenic epitope–escape variants, IgM+
cells can enter germinal centres and undergo affinity mat-
uration towards a variant epitope faster than naive cells.
It is not unreasonable to propose that a temporarily
expanded clone of CD21int CD23+ IgM+ B cells could
provide a similar advantage when pathogen epitopes were
too greatly mutated to bind to immunoglobulin on estab-
lished IgM+ memory cells. This would make follicular
cells the most ‘naive-like’22 part of the B-cell memory
compartment.
This study has also revealed another interesting aspect
of the expression of the VHOx-1//C6-containing antibody
in response to phOx. Both in our previous studies24 and
as reported here, there is little evidence for a VHOx-1/C6
IgM plasma cell response. The similarity between Figs 2
and 3 is notable, and implies that all or most of the
VHOx-1/C6 secretory IgM that we detect is follicular cell
derived. The uplift in splenic secretory IgM C6 after
priming and boosting, although higher than controls and
carrier primed controls is moderate when compared with
IgG,24 and undiminshed when only follicular cells are
analysed, Fig. 3. In unimmunized animals VHOx-1 IgG1
is hard to detect, but after boosting IgG1 C6 transcripts
alone saturate the RT-PCR.24 These observations imply
that all or almost all of the non-follicular IgM response
to phOx, including any T-independent part, is not using
the VHOx-1/C6 combination at the observed time-points.
This is consistent with earlier studies26 reporting that
VHOx-1 IgM hybridomas are rare and that depending on
the time-point and number of immunizations, 25–75% of
the phOx response does not use VHOx-1. Only one
mouse showed a VHOx-1/C6 response at day 4 after
immunization, which still partitioned to the
CD21int CD23+ population and so was expressed by cells
with the follicular phenotype. At this time, marginal zone
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Figure 3. The VHOx-1 secretory IgM response to phenyl-oxazolone (phOx) in the CD21int CD23+ population. VHOx-1 secretory IgM RT-PCR
of sorted CD21int CD23+ cell cDNA. Cells were from single mouse per sample track, three samples per group. For statistical calculations a further
three samples from an independent experiment for control and day 11 post-immunization samples were obtained for data in lower panel. The
extra C6%-level data-points not shown in upper panel, from the second experiment were: Control: 90, 43, 96; day 11: 158, 205, 182. Sample
time-points, derivation of numerical data and annotation as described in Fig. 2. Lower panel: shows individual C6 levels plotted (dots), the mean
for each group (solid bar) which may differ from upper panel because of the inclusion of extra samples, and the 95% confidence intervals for the
mean, calculated according to ref. 33; for n = 3 or 6 the 95% CI = 4 9 SEM. Confidence intervals not shown for day 4 samples because only
one individual showed response.
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CD21int CD23+ B cells express memory IgM
B-cell-derived31 and early follicular B-cell-derived32 anti-
body forming cell (AFC) formation has peaked, this also
suggests that these parts of the IgM antibody response to
phOx are not commonly using the VHOx-1/C6 combina-
tion.
This would explain why, when comparing the data and
profiles from Figs 2 and 3, that the bulk of the VHOx-1/
C6 secretory IgM response to phOx detected by this
method is produced by CD21int CD23+ cells. Finally, we
conclude this because the follicular cell population com-
prises around 80% of CD19+ splenic B cells, and enrich-
ing for them does not obviously change the VHOx-1/C6
expression profiles compared with whole spleen.
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